title: [Antidiabetogenic action of heparin during its oral administration].
abstract: Oral heparin given to rats was found to neutralize the hyperglycemic and hypoinsulinemic effects of diabetogenic factor and to produce a protective action by preventing the animals from the diabetogenic action of alloxan. The chronic oral heparin use alleviated the course of severe alloxan diabetes in rats, by contributing to the reduction of hyperglycemic levels, to the elevation of blood insulin concentrations, thus promoting their higher survival.
authors.forename: A M
authors.initials: AM
authors.lastname: Ul'ianov
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Tarasov
mesh_terms: D000284:Administration, Oral; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000517:prevention & control*; D006493:Heparin / Q000494:pharmacology*; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D051381:Rats
chemical_list: D006493:Heparin
vernacular_title: Antidiabetogennoe deĭstvie geparina pri ego peroral'nom vvedenii.